Latest filing published 03 Jun 2025 for 北陆药业.
宗利: trading record in brief
宗利 is a declared insider of 北陆药业 (board member), with filings sourced from SSE / SZSE (CSRC). In total, 7 filings cover trades dated from 7 June 2021 to 3 June 2025.
Every open-market trade on record is a sale: 7 sales worth €215k. So far in 2025, the count stands at no purchases and 1 sale.
On 3 June 2025 came the latest disclosure, an open-market sale for €9,220 in 北陆药业. Half of the filings or more reach the SSE / SZSE (CSRC) feed on the day of the trade. This delay matters because a trade only becomes useful information once it is public. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 宗利
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,200 sharesA股XSHESZSE:173000009010905570
- 8,000 sharesA股XSHESZSE:173000006953700030
- 20,000 sharesA股XSHESZSE:173000006628185470
- 5,000 sharesA股XSHESZSE:173000004832115900
- 10,000 sharesA股XSHESZSE:173000004832115940
- 60,000 sharesA股XSHESZSE:173000004706551200
- 60,000 sharesA股XSHESZSE:173000004706551230
7 of 7 declarations